No patient should have to wait weeks just to get their prescribed medication. But such is often the case for patients who are prescribed specialty medications by their doctor. New technology from Veradigm is helping clinicians change that.
Forum: Should outcomes-based pricing be the blueprint for all specialty drug launches?
March 13, 2018
9:14 pm
As drugmakers continue to experiment with novel pricing models for expensive new specialty drugs, MM&M asked a trio of industry insiders whether outcomes-based pricing should become standard.
4 Ways to Communicate the Value of Specialty Drugs
April 6, 2017
11:00 am
Beset by high prices and scientific complexity, how can marketers best communicate the value of specialty drugs?
Pricing debate changes perception of patient assistance programs
Shire offers to buy Baxalta for $30 billion; CVS reports strong sales in specialty pharmacy; Reuters reports that new drug launches hit 17-year high in 2014
Americans spent 13.1% more on prescription medications in 2014 than they did in 2013, but recent launches indicate competition in the specialty drug space is going to heat up.
Loading...
MM+M Transform: The Patient, Provider and Payer Engagement Matrix